Journal article
Cost-effectiveness of home-based care of febrile neutropenia in children with cancer
M Tew, R De Abreu Lourenco, JR Gordon, KA Thursky, MA Slavin, FA Babl, L Orme, PA Bryant, BW Teh, K Dalziel, GM Haeusler
Pediatric Blood and Cancer | Published : 2022
DOI: 10.1002/pbc.29469
Abstract
Introduction: Home-based treatment of febrile neutropenia (FN) in children with cancer with oral or intravenous antibiotics is safe and effective. There are limited data on the economic impact of this model of care. We evaluated the cost-effectiveness of implementing an FN programme, incorporating home-based intravenous antibiotics for carefully selected patients, in a tertiary paediatric hospital. Methods: A decision analytic model was constructed to compare costs and outcomes of the home-based FN programme, with usual in-hospital treatment with intravenous antibiotics. The programme included a clinical decision rule to stratify patients by risk for severe infection and home-based eligibili..
View full abstractRelated Projects (2)
Grants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
We gratefully acknowledge funding support from National Health and Medical Research Council (NHMRC) and Better Care Victoria and state-wide programme endorsement and support from the Victorian Paediatric Integrated Cancer Service. Michelle Tew is jointly supported by the NHMRC funded Centre for Research Excellence in Total Joint Replacement (1116325) and Centre for Improving Cancer Outcomes Through Enhanced Infection Services (1116876), Melbourne Research Scholarship and Australian Research Council Centre of Excellence in Population Ageing Research (CEPAR).